{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:50:58Z","timestamp":1794459058995,"version":"4.9.1"},"reference-count":51,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: This study aimed to evaluate the impact of myoinositol (MYO) and \u03b1-lipoic acid (ALA) supplementation on hormonal and metabolic markers in women diagnosed with polycystic ovary syndrome (PCOS). Materials and\u00a0Methods: A retrospective case\u2013control study was conducted with 58 women aged between 18\u201340 years who met the Rotterdam criteria for PCOS. The case group (n = 29) received MYO (2000 mg\/day) and ALA (400 mg\/day) supplements, while the control group (n = 29) did not receive any treatment. Data on the subjects\u2019 anthropometric measures, glycemic indices, sex hormones, and lipid profiles were collected. Results: The results demonstrated that, following three months of MYO + ALA supplementation, the case group exhibited steady body weight (p = 0.484) and BMI (p = 0.405), whereas the control group demonstrated a significant increase in both (p = 0.029; p = 0.026, respectively). A stratified analysis based on BMI, waist circumference, and waist-to-height ratio revealed that HbA1c (%) was significantly lower in the \u201cnormal\u201d subgroup compared to the \u201crisky\u201d subgroup within the case group (p &lt; 0.05). Although the mean HbA1c, insulin, and HOMA-IR values were comparable between the two groups, the LH\/FSH ratio significantly increased in the control group (p = 0.010). No significant differences were observed in the lipid profiles between the two groups; however, LDL levels decreased significantly in the case group (p = 0.024). Across all classifications, the \u201cnormal\u201d subgroup consistently exhibited lower HbA1c and TG\/HDL ratios than the \u201crisky\u201d subgroup. Conclusions: Adding MYO + ALA supplementation to standard PCOS treatment may offer metabolic benefits, particularly in maintaining glycemic control, body weight, and BMI. Supplementation also reduces LDL.<\/jats:p>","DOI":"10.3390\/medicina61050885","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:31:49Z","timestamp":1747135909000},"page":"885","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does MYO and ALA Supplementation Improve PCOS Outcomes?"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1477-2194","authenticated-orcid":false,"given":"Selma","family":"Firat","sequence":"first","affiliation":[{"name":"Department of Nutrition and Dietetics, Faculty of Health Sciences, K\u0131rklareli University, K\u0131rklareli 39100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7143-6037","authenticated-orcid":false,"given":"Koray","family":"Elter","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9650-8340","authenticated-orcid":false,"given":"Sinan","family":"Ate\u015f","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0021-7811","authenticated-orcid":false,"given":"Mehmet","family":"Fisuno\u011flu","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara 06100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Chang","year":"2004","journal-title":"Fertil. Steril."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_6","first-page":"267","article-title":"Polycystic ovary syndrome: Pathophysiology, molecular aspects and clinical implications","volume":"50","author":"Nardo","year":"2008","journal-title":"Panminerva Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1210\/jc.2005-2757","article-title":"Fetal programming of polycystic ovary syndrome by androgen excess: Evidence from experimental, clinical, and genetic association studies","volume":"91","author":"Xita","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00404-014-3433-z","article-title":"Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena","volume":"290","author":"Rondanelli","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/NDS.S119738","article-title":"Nutritional support and dietary interventions for women with polycystic ovary syndrome","volume":"9","author":"Papavasiliou","year":"2017","journal-title":"Nutr. Diet. Suppl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/advances\/nmab141","article-title":"Nutritional supplements and complementary therapies in polycystic ovary syndrome","volume":"13","author":"Alesi","year":"2022","journal-title":"Adv. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/09513590.2017.1313972","article-title":"Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action","volume":"33","author":"Immediata","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/09513590.2018.1462320","article-title":"Alpha lipoic acid in obstetrics and gynecology","volume":"34","author":"Vena","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40618-017-0782-z","article-title":"Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients","volume":"41","author":"Genazzani","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1471-0528.14754","article-title":"Inositol treatment of anovulation in women with polycystic ovary syndrome: A meta-analysis of randomised trials","volume":"125","author":"Pundir","year":"2018","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.36129\/jog.2022.40","article-title":"Inositols administration: Further insights on their biological role","volume":"35","author":"Coldebella","year":"2023","journal-title":"Ital. J. Gynaecol. Obstet."},{"key":"ref_16","first-page":"485","article-title":"Myo-inositol: From induction of ovulation to menopausal disorder management","volume":"67","author":"Gullo","year":"2015","journal-title":"Minerva Ginecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/09513590.2011.650660","article-title":"Effects of myo-inositol in women with PCOS: A systematic review of randomized controlled trials","volume":"28","author":"Unfer","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1849162","DOI":"10.1155\/2016\/1849162","article-title":"Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials","volume":"2016","author":"Unfer","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1021\/jf904403u","article-title":"Lipoic acid: An immunomodulator that attenuates glycinin-induced anaphylactic reactions in a rat model","volume":"58","author":"Ma","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbrc.2005.05.035","article-title":"\u03b1-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle","volume":"332","author":"Lee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"C1395","DOI":"10.1152\/ajpcell.00115.2007","article-title":"Ca2+\/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by \u03b1-lipoic acid in C2C12 myotubes","volume":"293","author":"Shen","year":"2007","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in health and disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Guarano, A., Capozzi, A., Cristodoro, M., Di Simone, N., and Lello, S. (2023). Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth?. Nutrients, 15.","DOI":"10.3390\/nu15143209"},{"key":"ref_26","first-page":"1241","article-title":"Does Alpha-lipoic acid improve effects on polycystic ovary syndrome?","volume":"26","author":"Monti","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-1017.1000140","article-title":"Effects of a combination of alpha lipoic acid and myo-inositol on insulin dynamics in overweight\/obese patients with PCOS","volume":"3","author":"Genazzani","year":"2014","journal-title":"Endocrinol. Metab. Synd."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40618-023-02210-4","article-title":"Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome","volume":"47","author":"Fruzzetti","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/09513590.2015.1014784","article-title":"D-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS","volume":"31","author":"Cianci","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"ref_30","unstructured":"Schmid, M. (2011). Beslenme Bilgi Sistemi BEB\u0130S 8.1 Paket Program, Entwickelt an der Universital Hohenheim."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1017\/S1368980013002115","article-title":"Designing and developing a literature-derived, population-based dietary inflammatory index","volume":"17","author":"Shivappa","year":"2014","journal-title":"Public Health Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3945\/jn.109.114025","article-title":"A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein","volume":"139","author":"Cavicchia","year":"2009","journal-title":"J. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/2230-8210.146874","article-title":"Assessment of insulin sensitivity\/resistance","volume":"19","author":"Gutch","year":"2015","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_35","unstructured":"World Health Organization (2000). Obesity: Preventing and Managing the Global Epidemic, World Health Organization."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1079\/BJN19910073","article-title":"Body mass index as a measure of body fatness: Age- and sex-specific prediction formulas","volume":"65","author":"Deurenberg","year":"1991","journal-title":"Br. J. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcn\/33.1.27","article-title":"The body water compartments: The influence of body weight and height on body water content","volume":"33","author":"Watson","year":"1980","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1073\/pnas.4.12.370","article-title":"A Biometric Study of Human Basal Metabolism","volume":"4","author":"Harris","year":"1918","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","unstructured":"Pekcan, G. (2008). Hastan\u0131n Beslenme Durumunun Saptanmas\u0131. Diyet El Kitab\u0131. 5, Hatibo\u011flu Yay\u0131nevi."},{"key":"ref_40","unstructured":"World Health Organization (2008). Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, WHO."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09637480500195066","article-title":"Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity","volume":"56","author":"Ashwell","year":"2005","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_42","first-page":"425","article-title":"Evaluation of a new association between insulin-sensitizers and \u03b1-lipoic acid in obese women affected by PCOS","volume":"65","author":"Cappelli","year":"2013","journal-title":"Minerva Ginecol."},{"key":"ref_43","first-page":"913","article-title":"Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: A pilot study","volume":"29","author":"Rago","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1745-6215-14-273","article-title":"Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: A randomized placebo-controlled trial","volume":"14","author":"Capasso","year":"2013","journal-title":"Trials"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09513590.2019.1640673","article-title":"Long-term treatment with alpha-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome","volume":"36","author":"Fruzzetti","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2901393","DOI":"10.1155\/2020\/2901393","article-title":"Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome","volume":"2020","author":"Fruzzetti","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/09513590.2020.1725967","article-title":"HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)","volume":"36","author":"Cirillo","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/09513590.2014.897321","article-title":"Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients","volume":"30","author":"Genazzani","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cjca.2012.06.023","article-title":"The biological role of inflammation in atherosclerosis","volume":"28","author":"Wong","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis","volume":"95","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S0954422418000136","article-title":"Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome","volume":"31","author":"Barrea","year":"2018","journal-title":"Nutr. Res. Rev."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/885\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:31:46Z","timestamp":1760031106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["medicina61050885"],"URL":"https:\/\/doi.org\/10.3390\/medicina61050885","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}